Le Lézard
Classified in: Health
Subjects: RCL, PSF

Viable Solutions, LLC Recalls Certain Kratom-Containing Powder Products Because Of Possible Health Risk


NAMPA, Idaho, April 18, 2018 /PRNewswire/ -- Viable Solutions of Nampa, ID has initiated a recall of certain Kratom-containing powder products, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

The potentially affected powder products are packaged in kaft paper, foil-lined heat sealed pouches and sold in 25 grams, 100 grams, 250 grams, and 1000 grams sizes. The units were sold directly to consumers nationwide in January and February of 2018 via company websites. The products description are as follows:

Recall Product Identification:

Brand

Product Name

Net Wt.

Herbal-Salvation.com

Mitragyna Speciosa Leaf
Powder-Red Vein Sumatra

25 grams, 100 grams, 250
grams, 1000 grams

Herbal-Salvation.com

Mitragyna Speciosa Leaf
Powder-Red Vein Bali

25 grams, 100 grams, 250
grams, 1000 grams

Herbal-Salvation.com

Mitragyna Speciosa Leaf
Powder-Green Horn

25 grams, 100 grams, 250
grams, 1000 grams

Herbal-Salvation.com

Mitragyna Speciosa Leaf
Powder-Thai Maeng Da

25 grams, 100 grams, 250
grams, 1000 grams

The lot numbers being recalled can be found on the packaging and are as follows:

Recalled Products have any of the following LOT Numbers

RVS1380182301

RVB1380182201

GVH1380171512

MD13120181601

The company has been notified by the Michigan Department of Health and Human Services (MDHHS) that certain lots of the product were tested positive for Salmonella. While the Salmonella has not been traced to Viable Solutions, out of an abundance of caution and concern for the public health, Viable Solutions has initiated this recall. Viable Solutions has identified the supplier and source of the potentially contaminated product and has ceased production and distribution of the potentially contaminated product. Working in cooperation with the FDA, the company will destroy all recalled product upon return.

Consumers who may be in possession of potentially contaminated products are advised not to consume products from those LOT numbers. All products associated with this recall should be returned to Viable Solutions for a full refund. Customers can return product to company for a full refund within fourteen (14) days by contacting Viable Solutions at [email protected].

 

SOURCE Viable Solutions, LLC


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: